Left ventricular ejection fraction (EF) is a ratio that is deemed to accurately normalize stroke volume (SV) to end-diastolic volume (EDV). Ratios are now well-recognized for not normalizing the numerator, in this case SV, consistently for the denominator, EDV. We aimed to provide the first allometric-based scrutiny of the conventional assumptions that underpin the EF ratio. We allometrically modelled untransformed SV and EDV measurements from 112 preclinical heart failure patients in the Multi-Ethnic Study of Atherosclerosis (MESA), and 864 chronic heart failure patients in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) study. An information-theoretic approach was adopted to assess the relative quality of twelve candidate models for normalizing SV to EDV. None of the conventional underlying assumptions for accurate ratio normalization, for example an allometric exponent %1, were upheld for EF. A two-parameter power function with normal, heteroscedastic error was the best model for scaling SV to EDV in both samples. The allometric exponent (95% confidence interval) was 0Á776 (0Á682 to 0Á869) in MESA, and 0Á860 (0Á857 to 0Á864) in TOPCAT. EF was inversely correlated with EDV in MESA (r = À0Á67, 95% CI: À0Á76 to À0Á55) and TOPCAT (r = À0Á41, 95% CI: À0Á46 to À0Á35). Consequently, for fundamental statistical reasons, EF was biased low for people with generally larger EDVs, and vice versa. For the first time, we have demonstrated that EF is an inaccurate statistic for scaling SV to EDV, leading to potential biased inferences for research and individual patients.
Introduction
Left ventricular ejection fraction (EF) is typically calculated as the ratio of stroke volume (SV) to end-diastolic volume (EDV) and expressed as a percentage statistic (Carabello, 2002) . Ejection fraction represents a criterion measure used to inform clinical decisions in the diagnosis and treatment pathways for heart failure (Dunlay et al., 2017) . Heart failure is a multifactorial clinical syndrome resulting from pathological impairments in cardiac function and morphology (Abudiab et al., 2013) and is estimated to affect more than 37Á7 million individuals worldwide (Ziaeian & Fonarow, 2016) . According to recent epidemiological data, hospital admissions due to heart failure are expected to increase by more than 50% by 2035 (Ziaeian & Fonarow, 2016) . In the United Kingdom, there are approximately 493 000 people living with a definite diagnosis of heart failure (Townsend et al., 2015) , which imposes a substantial economic burden on the UK's National Health Service, accounting for 2Á1% of its overall budget (Cook et al., 2014) .
Clinically, patients may often progress through a silent and asymptomatic phase of left ventricular systolic dysfunction that characterizes the transition from preclinical to overt heart failure (Goldberg & Jessup, 2006) . European guidelines for the diagnosis and treatment of acute and chronic heart failure (Ponikowski et al., 2016) differentiate patients with an EF < 40% as 'heart failure with reduced ejection fraction' (HFrEF), EF ≥ 50% as 'heart failure with preserved ejection fraction' (HFpEF), and a 'grey zone' in the range from 40% to 49% (HFmrEF). It has been reported that HF patients with a preserved EF have a 32% lower risk of mortality over a 3-year follow-up period compared with HF patients with a reduced EF (Meta-analysis Global Group in Chronic Heart Failure, 2012).
In a previous study, it was highlighted that 'in chronic, compensated heart failure with reduced EF, the EF is reduced because the chamber size (denominator of EF equation) is larger, whereas the stroke volume (numerator) is typically similar to that of normal controls' (Borlaug & Redfield, 2011; page 2008) . In classical allometry, EF is a ratio size-scaling index, the accuracy of which is reliant on SV varying as a constant proportion of EDV. Like many such ratio statistics, EF is a statistically robust measure of systolic function only if this assumption and other related assumptions are satisfied (Tanner, 1949; Albrecht et al., 1993; George et al., 2001; Curran-Everett, 2013) . For example, recently published studies have revealed that the percentage flow-mediated dilation index can misrepresent the true size-scaling association between resting and hyperaemic artery diameter, thereby entailing inaccurate inferences regarding human endothelial function (Atkinson & Batterham, 2015) .
As EF is the selected statistic for informing the diagnosis and treatment of patients with heart failure (Ponikowski et al., 2016; Dunlay et al., 2017) , we hypothesized that the true relationship between the left ventricular systolic and diastolic volumes might not be directly proportional in nature. It is this assumption which underpins the accuracy of the EF ratio statistic and, if false, would lead to biased inferences in research and diagnoses for individual patients. While studies on allometry and scaling in cardiovascular physiology have been traditionally conceived to standardize the measures of cardiac structure and function to body size (Dewey et al., 2008) , no previous study has comprehensively scrutinized the inherent scaling properties of the EF index itself, that is the inherent accuracy of how EF normalizes SV for differences in EDV.
Therefore, using a formal information-theoretic approach, we compared twelve candidate models for scaling SV to EDV in terms of the potential implications for general clinical practice using two samples of data (Studies 1 and 2). In study 1, we analysed data from preclinical heart failure patients enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA), and, in study 2, we analysed data from patients already with chronic HF involved in the Treatment of Preserved Cardiac Function Heart Failure with and Aldosterone Antagonist (TOP-CAT) echocardiographic substudy.
Methods Study 1 (MESA)

Study population and definitions
A detailed study protocol of the MESA has been previously reported (Bild et al., 2002) . In brief, the MESA is a prospective, population-based study on the prevalence, incidence and progression of subclinical cardiovascular disease (Bild et al., 2002) . For this study, participants at the baseline visit were selected based on the established diagnosis for incident heart failure after 8 years of follow-up (Habibi et al., 2014) . The adjudication of a hard cardiovascular event was established by a committee that included a cardiologist, an epidemiologist and a neurologist (Yeboah et al., 2012) . Incident heart failure was classified as definite, probable or absent (Yeboah et al., 2012) . The full criteria for the diagnosis of heart failure in the MESA were also detailed in previous studies (Bluemke et al., 2008; Yeboah et al., 2012) . The MESA was approved by the local institutional review boards of each study centre, and participants provided written informed consent. This study adhered to the ethics and research governance procedures at Teesside University.
Demographic, medical history, metabolic and cardiovascular data for this study were obtained at the MESA baseline examination. Resting blood pressure was determined as the average of the last two measurements in the seated position using a Dinamap model Pro 100 automated oscillometric sphygmomanometer (Critikon, Tampa, Florida). Hypertension was defined as systolic blood pressure >140 mmHg, diastolic blood pressure >90 mmHg, or the use of antihypertensive medication. Fasting plasma glucose ≥126 mg dl À1 or the use of anti-diabetic medications defined diabetes mellitus. The glomerular filtration rate (eGFR) was estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation (Levey et al., 2009) . Smoking history was determined via standardized questionnaires. Body mass index (BMI) was calculated as the ratio of weight to height squared (kg m À2 ). Lipid profiling from blood samples was performed after a 12-h fast. Low-density lipoprotein cholesterol was estimated with the Friedewald equation (Friedewald et al., 1972) .
Cardiac magnetic resonance imaging
The magnetic resonance imaging (MRI) protocol procedures and reliability of the global left ventricular measurements have been outlined previously (Natori et al., 2006) . Briefly, the MRI examination to quantify left ventricular functional and structural parameters consisted of a stack of short-and long-axis echo cine images covering the base-to-apex distance of the left ventricle with a temporal resolution of 50 ms (Natori et al., 2006) . The EDV and end-systolic volume (ESV) were calculated using the Simpson's rule from endocardial and epicardial myocardial borders (Natori et al., 2006) . Left ventricular mass was the resultant of the difference between epicardial and endocardial areas times the slice thickness, section gap and the specific gravity of the myocardium (i.e., 1Á05 g ml À1 ) (Natori et al., 2006) . Papillary muscle mass was included in the left ventricular cavity volume and excluded from left ventricular mass (Bluemke et al., 2008) . EF (%) was conventionally calculated as SV divided by EDV 9 100.
Study 2 (TOPCAT)
Study population and definitions
TOPCAT is an intercontinental, double-blind, randomized, placebo-controlled, parallel-group study involving 3445 HF patients recruited at 266 centres in United States, Canada, Russia, Republic of Georgia, Argentina and Brazil to test the efficacy and safety of an aldosterone antagonist to reduce cardiovascular morbidity and mortality in patients with heart failure and an EF ≥ 45% (Desai et al., 2011) . This study examined participants enrolled in the TOPCAT echocardiographic substudy, a smaller sample from the TOPCAT trial (Shah et al., 2014) . Participants were eligible if they had a technically valid echocardiographic quantification of the left ventricular volumes derived according to the modified biplane Simpson's rule, which represents the recommended method by the American Society of Echocardiography (Lang et al., 2015) . The TOPCAT trial was funded by the National Heart, Lung, and Blood Institute (NHLBI) and was approved by the local institutional review boards of each study centre (Pitt et al., 2014) . This study was compliant with the ethics and research governance procedures at Teesside University. At the baseline visit, each participant underwent record screening, which included self-reported medical history and current medications, a physical examination (e.g., blood pressure, height, weight) and laboratory data collection involving complete blood count, electrolytes, blood urea nitrogen, creatinine, blood glucose, liver function assessment and urine test for microalbuminuria. (Pitt et al., 2014; Shah et al., 2014) . Participants' chronological age, the inverse of serum creatinine, sex and ethnicity were obtained to derive eGFR using the four-variable Modification of Diet in Renal Disease algorithm (Levey et al., 1999) .
Echocardiography
The echocardiographic assessments, procedures and intraobserver measurement variability in the TOPCAT echocardiographic substudy have been described in detail previously (Shah et al., 2014) . Each study centre submitted echocardiograms in digital or analogue format to the core laboratory at the Brigham and Women's hospital (Desai et al., 2011) . Left ventricular endocardial borders were traced manually at the end of the diastolic and systolic phases in the 4-and 2-chamber apical views (Shah et al., 2014) . The biplane method of discs (i.e., modified Simpson's rule) was adopted to assess left ventricular volumes. Left ventricular mass estimation from linear dimension was performed according to the American Society of Echocardiography equation (Lang et al., 2015) . Of the 935 echocardiographic measurements that were analysable quantitatively, left ventricular volumes derived via the modified biplane Simpson's rule were available in 864 study participants.
Statistical analyses and allometric modeling
The MESA (n = 112) and TOPCAT (n = 864) samples were examined separately. Demographic and clinical characteristics of participants at the baseline examination are presented as mean AE standard deviation (SD) for continuous variables and frequency or percentages for categorical variables.
To examine the scaling relationship between SV and EDV, we performed non-linear regression analyses of untransformed measurements. We fitted three sets of four models, involving two straight lines and two power functions, with multiplicative, log-normal, heteroscedastic error, and additive, normal, homoscedastic or heteroscedastic error, respectively (Packard, 2017b) . Parameter estimates for each model were solved using an iterative protocol based on the Marquardt procedure (Packard, 2017b) . Participants' chronological age and sex (coded '0' for female, '1' for male) were included as continuous and categorical covariates in the models, respectively. The commonality of b exponent principle was tested to establish the presence of a common EDV exponent for both sexes (Batterham et al., 1997; Vanderburgh, 1998) . A substantial sex difference in the allometric exponent, predefined as AE0Á1 in this study, would reveal a fundamental difference in the relationship between SV and EDV, thereby precluding meaningful comparisons between men and women (Batterham et al., 1997; Vanderburgh, 1998) .
The Akaike Information Criterion (AIC) was adopted to assess the relative quality of each model in the set of candidates (Burnham et al., 2011) . The Akaike difference (DAIC) from the estimated best model (i.e. the model with the lowest AIC value; DAIC = 0) was evaluated according to the following scale: 0-2, essentially equivalent; 2-7, plausible alternative; 7-14, weak support; >14, no empirical support (Burnham et al., 2011) . Parameter estimates were interpreted from the best/essentially equivalent models for the examined data. Regression coefficients were reported as point estimates with 95% confidence intervals (CI). Statistical analyses were carried out using SAS â software (PROC MODEL, version 9Á3; SAS Institute, Inc., Cary, NC, 2011), and figures were produced using IBM Statistical Package for the Social Sciences (SPSS) Statistics v. 23Á0 (SPSS, Chicago, IL, USA).
Results
Allometric accuracy of the EF ratio in preclinical individuals (MESA)
Among 5004 study participants with technically valid measurements of the left ventricle obtained at the baseline visit, 112 participants reported a subsequent diagnosis of heart failure at 8 years of follow-up. Of these participants, 43% were Caucasian (n = 48), 5% Chinese (n = 5), 31% African-American (n = 35) and 21% Hispanic (n = 24). Table 1 shows the summary data of the 112 study participants stratified by sex. Graphical and statistical criteria indicated that the EF ratio failed to meet underlying assumptions for appropriate scaling. First, there was a large, negative correlation between the ratiometric index and its denominator corresponding to r = À0Á67 (95% CI: À0Á76 to À0Á55). This inconsistent normalization for EDV is also shown in Fig. 1a . Second, the linear regression between SV and EDV for the whole sample revealed a positive Y-intercept value of 44 ml (95% CI: 34 ml to 54 ml). Use of a ratio would only be appropriate if the line describing the bivariate relationship passes through the origin (Fig. 1c) . Accordingly, the ratio of the coefficient of variations (CV) for EDV to SV was substantially different from the correlation coefficient describing the bivariate relationship between the two variables (1Á31 6 ¼ 0Á68). A ratio standard model is valid only if this ratio of CVs is equal to the correlation coefficient between SV and EDV.
The AIC criteria revealed the two-parameter power function with normal, heteroscedastic error, of the form Y = aX b (Fig. 2a) , to be the best of the twelve models (Table S1 ). The allometric exponent (b) describing the non-linear relationship between SV and EDV was 0Á776 (95% CI: 0Á682 to 0Á869), with no main effects of chronological age and sex as predictor variables in the model. The mean difference in the EDV exponent between men and women was 0Á073 (95% CI: À0Á090 to 0Á235). The EDV measurement spectrum ranged from 47 to 290 ml. Table S1 shows the AIC values for each model in the set of candidates. In agreement with the AIC outcomes, the raw residuals from the best model were well-behaved (Fig. 2c) .
Allometric accuracy of the EF ratio in clinical individuals (TOPCAT)
Among the 864 eligible study participants, 83% were Caucasian (n = 714), 13% were Black (n = 114), less than 1% Asian (n = 4) and 3% (n = 30) were defined as a minor mixed-ethnic group. Demographic and cardiovascular functional parameters of the 864 study participants are illustrated in Table 1 .
The moderate, inverse association between the ratiometric EF and EDV corresponding to r = À0Á41 (95% CI: À0Á46 to À0Á35) demonstrated that the conventional ratiometric EF index does not consistently control for the effects of EDV (Fig. 1b) . Likewise, the positive Y-intercept value of 13 ml (95% CI: 11 ml to 14 ml) observed in the bivariate relationship between SV and EDV indicated the failure of the ratiometric EF to meet another underlying assumption of ratio scaling models (Fig. 1d) . In fact, the substantial difference between CVx/CVy and the observed correlation coefficient between SV and EDV (1Á12 6 ¼ 0Á88) provided additional evidence about the inappropriateness of the EF ratio also for this ) were derived directly from the model residuals working in the raw arithmetic data space, with the ratiometric EF or LV stroke volume as the dependent variable and LV end-diastolic volume, chronological age, and sex as predictors. Each participant's residual was added to the predicted mean ratio at the mean LV end-diastolic volume in the whole sample, to obtain an adjusted EF or LV stroke volume free from the influence of LV end-diastolic volume (Laird, 1983; Albrecht et al., 1993) . The normalized index (footnote b ) was directly derived from the ratio of LV stroke volume to end-diastolic volume raised to the power of 0Á78 and 0Á86 in the MESA and TOPCAT samples, respectively. a Two-parameter power function with normal, heteroscedastic error. b Power function ratio. c Indicates missing observations. EF, left ventricular ejection fraction; BMI, body mass index; eGFR, estimated glomerular filtration rate; LV, left ventricular. data set. The two-parameter power function with normal, heteroscedastic error, of the form Y = aX b (Fig. 2b) , emerged as the best model in the pool of twelve candidates (Table S2 ). The allometric exponent (b) describing the non-linear relationship between SV and EDV was 0Á860 (95% CI: 0Á857 to 0Á864), with a substantial main effect of chronological age in the model. The mean difference in the EDV exponent between men and women was 0Á087 (95% CI: 0Á080 to 0Á093). The EDV measurements ranged from 27 to 233 ml for this TOP-CAT subsample. The AIC values for each model in the set of candidates are shown in the Table S2 . The raw residuals from the best model plotted against the predicted values were found to be well-behaved (Fig. 2d) .
How the EF ratio can misdiagnose individuals
In both MESA and TOPCAT, application of allometric scaling methods revealed a substantial discrepancy between ratio and adjusted estimates of EF for some individuals on a betweensubject basis. For example, in MESA, a 64-year-old Caucasian man with no history of hard cardiovascular event, hypertension, a fasting glucose level of 87 mg dl À1 , and eGFR of
, and a blood pressure of 124/73 mmHg presented an SV of 91 ml within the age-specific range. On the other hand, left ventricular EDV (251 ml), ESV (160 ml), and mass (254 g) were markedly outside the physiological parameters. Although the calculated EF ratio was 36%, use of the more appropriate size-scaling model revealed an adjusted EF of 41%. The allometric normalization of SV for differences in EDV in MESA thus revealed an absolute underestimation of the relative systolic function for this individual corresponding to 5%. In TOPCAT, ratio and allometric scaling approaches were found to provide substantially different estimates of EF in a 77-year-old Caucasian woman with history of angina, hypertension, atrial fibrillation, a fasting glucose level of 91 mg dl À1 , an eGFR of 70Á2 ml min À1 1Á73 m À2 Figure 1 Scatterplots showing the inverse relationship between the ratiometric EF and EDV in MESA (a), r = À0Á67 (95% CI: À0Á76 to À0Á55) and TOPCAT (b), r = À0Á41 (95% CI: À0Á46 to À0Á35), and linear bivariate relationship between SV and EDV in MESA (c), r = 0Á68 (95% CI: 0Á57 to 0Á77), Y-intercept = 44 ml (95% CI: 34 ml to 54 ml) and TOPCAT (d), r = 0Á88 (95% CI: 0Á86 to 0Á89), Y-intercept = 13 ml (95% CI: 11 ml to 14 ml).
and on b-blockers therapy. The observed left ventricular EDV, ESV, SV and mass were 48 ml, 23 ml, 25 ml and 256 g, respectively. Notwithstanding the relatively small SV observed in this patient, the EF ratio of 52% indicated a preserved systolic function. Conversely, the more appropriate adjusted EF estimate of 47% revealed a substantial 5% overestimation of the true EF. Accordingly, the most appropriate size-scaling model provided a more sensible estimate of EF, ultimately in line with the abnormal global longitudinal strain of À13% observed in this patient.
Discussion
For the first time, we report here that SV does not vary in direct proportion to EDV. The use of the EF ratio must, as a fundamental assumption for accuracy, be used only when the association between numerator and denominator is directly proportional in nature. This incompatibility of the EF ratio has far-reaching implications, including the potential for biasing clinical and physiological insights into the human left ventricular systolic function. Specifically, estimates of relative SV are biased low for larger EDV measures, and vice versa. We contend that, although the EF ratio index is simple to calculate, it can contribute to misdiagnoses in heart failure ( Fig. 2  a,b) . Of the 23 patients who were found to have a reduced EF in the TOPCAT sample, five of these patients (22%) were misclassified. In fact, the mean difference of 3Á6% (95% CI: 2Á6% to 4Á5%) between the ratiometric and allometrically adjusted EF estimates indicated that these patients had a mid-range EF. We also highlight the fact that, in the TOPCAT study, HFpEF patients were specifically recruited (Desai et al., 2011; Pitt et al., 2014; Solomon et al., 2016) . As a consequence, only approximately 3% of the patients in the TOPCAT sample had a reduced EF. This proportion would be substantially larger in a random sample of HF patients, as would the range of measured EDVs. For example, in the PREVEND study, at a median follow-up of 11Á5 years, the reported proportion of patients with HFrEF was 66% (Brouwers et al., 2013) . Therefore, a 'reduced' misclassification proportion of 22% could have wider ramifications in a random sample of HF patients. In both the MESA and TOPCAT samples, the AIC criteria indicated that the two-parameter power function with normal, heteroscedastic error was the superior model for describing left ventricular systolic function rather than the EF ratio model of straight line with zero intercept (Tables S1 and S2 ). The EDV scaling exponents observed in both MESA and TOPCAT samples described unambiguously the negative allometric relationship (b < 1) between the volume of blood pumped from the ventricle during each cardiac cycle and atrial filling at the end of the diastolic phase both in preclinical and overt heart failure patients (Packard, 2017a) . A simple ratio would have empirical and physiological support only if these allometric exponents were found to be equivalent to 1. Furthermore, as a potential solution to the scaling problems with EF ratio, the present study provides a novel approach to derive EF measures adjusted properly for EDV differences working in the raw arithmetic space and using the residuals from the best model (Albrecht et al., 1993) .
Our study findings also appeared to shed light on the reported sex differences in EF both in healthy (Chung et al., 2006; Yeon et al., 2015) and diseased (Davies et al., 2001; Martinez-Selles et al., 2012) populations, whereby women typically show a higher EF compared with men. Yeon and colleagues, who examined a large subpopulation of the Framingham Heart Study Offspring Cohort (n = 1794) using cardiac MRI, reported a mean (AESD) EF of 68% AE 5 in women and 66% AE 5 in men (Yeon et al., 2015) . Nevertheless, the observed EDV was found to be substantially smaller in women than in men (Yeon et al., 2015) . Indeed, the mean sex-based differences we observed in absolute EDV both in MESA and TOPCAT samples were in line with the current evidence (Salton et al., 2002; Gori et al., 2014; Yeon et al., 2015) . The 95% CI for the mean EDV difference between men and women was 23 ml to 59 ml in MESA, and 22 ml to 30 ml in TOPCAT. On the other hand, application of allometric scaling methods revealed trivial sex-based differences in EF (Table 1) . Specifically, in MESA, the observed mean difference of 5Á7% (95% CI: 1Á0% to 10Á5%) indicated that women had a substantially greater EF ratio than men. Conversely, there was a trivial difference in EF of 1Á6% (95% CI: À2Á5% to 5Á8%) between the sexes based on allometrically adjusted individual EF estimates. Likewise, trivial differences in the adjusted EF were also observed in the larger TOPCAT population. While EF ratio estimates indicated a substantial difference of 2Á6% (95% CI: 1Á6% to 3Á7%) between the sexes, the observed mean difference in the adjusted EF of 0Á5% to (95% CI: À0Á5% to 1Á5%) was again found to be trivial.
Not only did the procedures used for normalizing left ventricular SV relative to EDV unveil the unappreciated potential of the EF ratio% to provide biased individual estimates, but they also permit an accurate determination of properly normalized EF measures (Laird, 1983; Albrecht et al., 1993) for new clinical patients showing hallmarks akin to the reference population. Conceptually, the sum of a new heart failure patient's individual residual (Albrecht et al., 1993) , by definition the difference between the observed and predicted EF, and the reference MESA sample mean EF of 63Á7% can provide the clinician with a size-adjusted measure of EF for the new person examined in the clinic. The prediction equation resulting from the best model parameter estimates in MESA (Table S1) , with the EF ratio as the dependent variable, was EF = 1Á74298 9 EDV À0Á22326 9 exp(chronological age 9 0Á001831) 9 exp(sex 9 À0Á03121) and yields a predicted estimate of EF. To illustrate further the importance of the proposed approach, we also reexamined here the clinical case of a patient with a definite diagnosis of heart failure, known chronological age, sex and left ventricular functional parameters measured between 2010 and 2012 as part of the fifth examination of MESA (Liu et al., 2013) . Demographic characteristics and parameters of cardiac function were obtained for a 76-year-old African-American woman with no history of myocardial infarction or coronary heart disease, hypertension, treated diabetes, a blood pressure of 149/84 mmHg, an eGFR of 30Á2 ml min À1 1Á73 m À2 and on b-blockers therapy.
Left ventricular EDV (114 ml), ESV (51 ml), SV (63 ml) and mass (140 g) measures were within the physiological parameters (Natori et al., 2006) . While the EF ratio of 55% was substantially above the threshold defining HFpEF, the more appropriate adjusted EF was a lower 49% and revealed a substantial overestimation of the true relative systolic function corresponding to 6%. A similar trend was observed in the case of a follow-up assessment for a 64-year-old Caucasian man with a definite diagnosis of heart failure in MESA (Liu et al., 2013) . The patient presented a history of myocardial infarction, coronary heart disease, hypertension, sinus bradycardia, treated diabetes, a blood pressure of 143/72 mmHg, an eGFR of 77Á9 ml min À1 1Á73 m À2 and was on b-blockers therapy. Left ventricular EDV (235 ml), ESV (142 ml) and mass (233 g) measures were substantially elevated, whereas the observed SV (93 ml) was within the physiological parameters (Natori et al., 2006) . While the EF ratio of 39% allegedly suggested an HFrEF diagnosis (Ponikowski et al., 2016) , the more appropriate allometrically adjusted EF was a higher 47% and revealed a substantial underestimation of the true relative systolic function corresponding to 8%. From a clinical standpoint, the approach described herein is deemed superior to the traditional formulation of power function ratios (Y/X b ), which typically display distributional patterns dependent on the size of the scaling variable (Albrecht et al., 1993) . In a failing heart, it is well-established that changes in EDV are likely to affect EF to a much greater extent than potential differences in SV, which typically tend to be of a smaller magnitude (Cohn et al., 2000) . With use of the traditional EF ratio index, substantial and uncontrolled variations in EDV have the unappreciated potential of generating artefactual variability in the estimated amount of fractional volume that is ejected during each cardiac cycle, regardless of the observed SV (Konstam, 2003) . A landmark study on the pathophysiological characterization of heart failure revealed trivial differences in SV between patients with chronic heart failure and healthy controls (Kitzman et al., 2002) . In contrast, the mean EF was substantially higher in people with HFpEF compared with the observed values in both HFrEF patients and, paradoxically, healthy participants (Kitzman et al., 2002) . Similarly, the mean EF was found to be larger in patients with left ventricular hypertrophy than healthy individuals despite significantly smaller left ventricular chamber dimensions (Aurigemma et al., 1995) . Additionally, a recent study has demonstrated the unappreciated impact of geometric confounders, primarily increased wall thickness and reduced EDV, hindering a reliable interpretation of EF (Stokke et al., 2017) . Despite significant and proportional reductions in SV and, more importantly, EDV which could result in a preserved EF, global longitudinal and circumferential strain can yet be substantially impaired (Stokke et al., 2017) . This line of evidence, alongside our study findings (Fig. 1) , appears to underline further the potential inadequacy of a EF ratio for stratifying cardiovascular patients as, for example, the development of an increased relative wall thickness could allow a preserved EF irrespective of a depressed myocardial shortening (Aurigemma et al., 1995) . As the physiological range of SV is finite, any substantial increase in EDV would result in a consequent inflation of the ESV and concomitant reduction of EF or vice versa (Li, 1996) . In relative terms, lack of adequate control for pathophysiological changes in cardiac morphology influencing left ventricular cavity volume in diastole can bias the EF ratio and, ultimately, lead to misclassifying a patient's clinical profile (Konstam, 2003) . Furthermore, the seldom appreciated drawbacks of adopting a ratiometric scaling approach may also provide an index of relative systolic function spuriously labile to any variation in preload and afterload (Carabello, 2002; Kalogeropoulos & Butler, 2017) . When SV is appropriately scaled to EDV using allometric methods, the confounding effects of EDV differences can be therefore removed and allow clinically meaningful inter-individual and group comparisons.
Limitations
Notwithstanding the fact that we examined the scaling relationship between SV and EDV among both preclinical and chronic heart failure patients, missing observations of cardiac structure and function of patients with acute decompensated heart failure limit a general application of the observed outcomes for taxonomic classifications in the ensuing stages of this pathological disorder. Additionally, the adoption of different imaging techniques for the assessment of left ventricular volumes in MESA and TOPCAT could be another limitation of the present study, even though the point estimates of the EDV exponents were not found to be substantially different between the samples (Fig. 2a,b) . Finally, the distribution of EF frequencies, and implicitly the relatively small left ventricular volumes, might have influenced the precision of the point estimate for the EDV allometric exponent due to the substantially greater proportion of participants with a EF ratio ≥50%. These results appear to warrant further research investigating the scaling properties of the EF index using allometric methods in large samples of acute and chronic heart failure patients being heterogeneous in left ventricular size, and the related implications from clinical and epidemiological perspectives.
Conclusions
Ratio scaling appears to limit the validity of EF as the traditional measure of the human systolic function unless it is adequately normalized for differences in EDV. The residual size correlation of a EF ratio might preclude a clinically meaningful assessment of cardiac function, ultimately yielding substantially biased estimates of EF for some individuals. A comprehensive integration of absolute measures of the heart function (i.e., left ventricular ESV), clinical parameters and relevant biomarkers might embody a more pragmatic approach for the optimal pre-emptive screening, decision-making, and, therapeutics than the limited scrutiny of a ratiometric EF index failing to serve its purpose in an unbiased manner. Further research will be required to examine scaling properties of the EF% index within large, heterogeneous populations of healthy and diseased individuals for determining the construct validity of the index as a clinical biomarker for risk stratification and therapeutic decisions.
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